Organon & Co reported 229M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Bristol-Myers Squibb USD 1.77B 1.2B Jun/2025
Celltrion KRW 195.49B 78.5B Mar/2025
Cspc Pharmaceutical CNY 833.21M 111.17M Dec/2024
Dianthus Therapeutics USD -31629000 3.19M Jun/2025
Divis Laboratories Ltd 7.33B 1.31B Jun/2025
Gilead Sciences USD 2.43B 780M Jun/2025
Glaxosmithkline USD 1.89B 230.76M Jun/2025
Kangmei Pharma -5720000 15.38M Sep/2024
Knight Therapeutics CAD -7144000 19.01M Mar/2024
Laboratorios Farma 26.78M 94.77M Jun/2025
Medical Developments International AUD -6390000 0 Dec/2023
Merck USD 6.77B 864M Jun/2025
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Novartis USD 4.53B 133M Jun/2025
Organigram Holdings CAD -16200000 6.76M Jun/2025
Organon & Co 229M 128M Jun/2025
Pharma Mar EUR 23.35M 27.26M Jun/2025
Qiagen NV USD 126.82M 7.27M Jun/2025
Sartorius EUR 70.9M 28.6M Jun/2025
Tilray USD -83239000 49.47M Nov/2024